| Literature DB >> 29264079 |
Yoshio Hisata1,2, Eisuke Sasaki3, Koutaro Ishimaru3, Yousuke Harada3, Hirohumi Nakano3, Shinji Naitou3, Takashi Sugioka2.
Abstract
Hearing loss is often the only symptom of OMAAV at initial presentation, thus making early diagnosis difficult. We present OMAAV in a 70-year-old woman with hearing loss and dry cough. Otoscopy showed otitis media with effusion. Audiometry showed mixed hearing loss, especially in the right ear. Serum myeloperoxidase antineutrophil cytoplasmic antibody was positive. Image analyses showed lung lesion and interstitial pneumonia, while bronchoscopy showed possible microscopic polyangiitis. After starting and tapering prednisolone, respiratory and otologic symptoms improved. When examining patients with acute otologic symptoms and suspected lung and/or renal disease, OMAAV should be included in differential diagnosis.Entities:
Keywords: ANCA; MPA; OMAAV; hearing loss; otitis media; vasculitis
Year: 2017 PMID: 29264079 PMCID: PMC5729317 DOI: 10.1002/jgf2.112
Source DB: PubMed Journal: J Gen Fam Med ISSN: 2189-7948
Figure 1Otoscopy (A) and audiometry (B). Intervention helped improve reddening and thickening of the right tympanic membrane (A‐left) (see auditory ossicles, A‐right), and mixed hearing loss (B‐left) was also recovered (ie. became hearing without difficulty, 1B‐right)
Laboratory data
| Variable | Units |
|---|---|
| RBC | 3.46×106/μL |
| Hb | 10.3 g/dL |
| Ht | 31.5% |
| MCV | 91 fL |
| WBC | 8.21×103/μL |
| Neutro | 67% |
| Lympho | 26% |
| Eosino | 5% |
| Mono | 1% |
| Baso | 0% |
| PLT | 180×103/μL |
| PT‐time | 14.3 s |
| PT‐activity | 71.7% |
| PT‐INR | 1.15 |
| APTT | 44.5 s |
| TP | 7.4 g/dL |
| Alb | 2.8 g/dL |
| T‐Bil | 0.34 mg/dL |
| AST | 17 IU/L |
| ALT | 15 IU/L |
| LDH | 190 IU/L |
| γ‐GTP | 90 IU/L |
| BUN | 12.8 mg/dL |
| Cr | 0.34 mg/dL |
| Na | 140 mEq/L |
| K | 4.4 mEq/L |
| Cl | 104 mEq/L |
| Ca | 8.5 mg/L |
| CRP | 5.6 mg/L |
Additional laboratory data
| Variable | Units | Normal range |
|---|---|---|
| Protein fraction (Alb) | 44.5% | 60.2‐71.4 |
| α‐1 | 3.9% | 1.9‐3.2 |
| α‐2 | 14% | 5.8‐9.6 |
| β | 10% | 7‐10.5 |
| γ | 27.6% | 10.6‐20.5 |
| IgG | 2064 mg/dL | 870‐1700 |
| IgA | 415 mg/dL | 110‐410 |
| IgM | 228 mg/dL | 40‐260 |
| C3 | 146 mg/dL | 65‐135 |
| C4 | 31.1 mg/dL | 13‐35 |
| ANA | <40 | 0‐80 |
| PR3‐ANCA | <0.5 IU/mL | 0‐2 |
| MPO‐ANCA | 18.4 IU/mL | 0‐3.5 |
| ACE | 8.7 U/L | 6.6‐21.4 |
| IL‐2R | 1014 U/mL | 122‐496 |
Figure 2Radiological study (A, B) and histological image (C). Multiple consolidations with ground grass opacity were at the apical–posterior segment of the right superior lobe, the superior segment of the right inferior lobe, the apicoposterior segment of the left superior lobe, and the anterior segment next to the left hilar area (B) ‐above Lung biopsy showed interstitial fibrosis, fibrous thickening of the alveolar wall, and mild inflammatory cell infiltration (C). Abnormal shadows disappeared 2 months after treatment (A, B‐below)